This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit July 02, 2014


 

Advertisement

Game changer for leukemia therapy
Oncology Nurse Advisor
Cancer cells decide whether to live or die after a short period of intense exposure to targeted therapy, opposing the current requirement for continuous treatment, according to a new study. The researchers, led by the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide's Centre for Personalised Cancer Medicine in Adelaide, Australia, say this study presents a new treatment strategy that will translate to a significant reduction in side effects for patients. The results have been published in Leukemia.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Presurgical SPECT/CT shows more cancer than current standard
Oncology Nurse Advisor
Startling data from an international multi-center trial provide growing evidence that sentinel node imaging is more effectively accomplished with hybrid functional imaging with single photon emission computed tomography (SPECT) and computed tomography (CT) than with another molecular imaging technique called lymphoscintigraphy. This conclusion held after imaging a range of cancers displaying a variety of lymphatic drainage types associated with melanoma, an aggressive skin cancer; breast carcinoma; and malignancies of the pelvis, such as prostate and cervical cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Accreditation 101 — Learning the Basics of CoC Accreditation and Standards
Commission on Cancer
Plan now to attend Accreditation 101 — Learning the Basics of CoC Accreditation and Standards in San Antonio, Texas, on Friday, September 12, 2014. The program agenda will provide information on how to meet the standards and prepare for your accreditation survey. Review the program brochure and see for yourself why the February program sold out! Register today, and do not forget to make your hotel reservation while space is still available.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


The NAPBC wants to hear from you
NAPBC
The National Accreditation Program for Breast Centers (NAPBC), a quality program of the American College of Surgeon (ACS) is looking for your feedback regarding future education program topics and locations. No matter your current NAPBC accreditation status (currently NAPBC accredited, in the process of re-accreditation, in the application phase, or considering NAPBC accreditation) your input is valuable. Please take a few minutes to help us set the future direction of NAPBC education by responding to the three question survey. Follow NAPBC on Twitter! @NAPBC_ACS
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Aspirin may cut pancreatic cancer risk
The New York Times
A new study adds to the evidence that low-dose aspirin, known to reduce the risk for heart disease, may also reduce the risk for pancreatic cancer. Pancreatic cancer has a 93 percent fatality rate, and the National Cancer Institute estimates there will be about 46,000 new cases and 40,000 deaths from the disease this year. In a five-year study, published online in Cancer Epidemiology, Biomarkers & Prevention, researchers compared aspirin use in 362 pancreatic cancer patients with 690 randomly chosen controls.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  NCBC: YOUR ONE STOP NAV SOURCE
Read more about how membership in NCBC provides a one-stop resource center for education and certification in comprehensive navigation programs. Click onto the attached links for timely and local information that helps to meet CoC standards in patient-centered care!
  • NAPBC Patient Navigation Standard
  • Portland Certification
  • NCBC Certification – NAPBC Standard
  •  


    2014 Commission on Cancer Annual Update notification
    Commission on Cancer
    All Commission on Cancer (CoC)-accredited programs scheduled for survey during 2015-2016 should note that the Program Activity Record (PAR) Annual Update period will run from July 1 to September 30, 2014. In order to maintain your CoC accreditation, your program must complete this activity within the specified timeframe. No extensions will be granted. Questions about the PAR or Annual Update should be e-mailed to SAR@facs.org. Questions regarding your CoC Datalinks user ID and password should be emailed to CoCdatalinks@facs.org.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Genetics dominant risk factor in common cancers
    Medical Xpress
    A study of individuals who have been adopted has identified genetics as the dominant risk factor in "familial" breast, prostate, and colorectal cancers. Researchers at the Centre for Primary Health Care Research at Lund University and Region Skåne in Sweden have presented the new research findings based on studies of population registers.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    3-D mammograms improve breast cancer detection, drive down false alarms
    Los Angeles Times
    Screening women for breast cancer using traditional digital mammography plus a technique that yields a three-dimensional picture of the breast improves detection of cancer and reduces the number of women called back unnecessarily for further tests and biopsies, a new study has found. The addition of tomosynthesis, a technique not widely available before 2011, to digital mammography increased the number of cancers found in women screened from 0.42 percent to 0.54 percent — a 29 percent increase.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Necitumumab plus chemotherapy improved PFS, OS in squamous NSCLC
    Healio
    The addition of necitumumab to gemcitabine and cisplatin significantly improved PFS and OS in patients with stage IV squamous non–small-cell lung cancer, according to results of the phase 3 SQUIRE trial presented at the ASCO Annual Meeting. “Squamous cell lung cancer is an important part of the lung cancer profile, accounting for 25 percent to 30 percent of our patients,” investigator Nick Thatcher, MD, professor of oncology at University of Manchester, said during a presentation.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Almost three-quarters of skin cancers OK for Mohs surgery
    HealthDay via Medical Xpress
    Application of recently published appropriate-use criteria suggests Mohs micrographic surgery (MMS) can be used in nearly three-quarters of skin cancers, according to a study published in the July issue of the Journal of the American Academy of Dermatology. Adam B. Blechman, MD, from the University of Virginia Health System in Charlottesville, and colleagues retrospectively identified all biopsy-proven skin cancers, excluding invasive melanoma, treated over an eight-month period using medical records (1,059 skin cancers).
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    Evolving role of genomic testing in RCC
    OncLive
    Kidney cancer is not a single disease, but rather is made up of several different types of cancer, including, for example, clear cell renal cell carcinoma (RCC), type 1 and type 2 papillary RCC, chromophobe RCC, and oncocytoma, notes Robert Figlin, MD. The role of genomic testing in kidney cancer is evolving, and Figlin questions whether molecular testing is useful in RCC to help identify actionable mutations and guide treatment selection.
    Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
    READ MORE


    TRENDING ARTICLES
    Missed last week's issue? See which articles your colleagues read most.

        Too much sitting may raise risk for certain cancers, study finds (CBS News)
    Skin moles tied to breast cancer risk: Studies (Reuters Health)
    U.S. cancer survivors face significant economic burden (Centers for Disease Control and Prevention)
    Lipids help to fight leukemia (Medical Xpress)
    Promising results from new therapy for pancreatic cancer (Oncology Nurse Advisor)

    Don't be left behind. Click here to see what else you missed.
     
    Advertisement



    The CoC Brief

    Colby Horton, Vice President of Publishing, 469.420.2601
    Download media kit

    Samantha Emerson, Content Editor, 469.420.2669
    Contribute news

    Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


    Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

    This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

    Recent issues

    June 25, 2014
    June 18, 2014
    June 11, 2014
    June 4, 2014






    7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063